GENERATION, TRAPPING AND FATE OF ALKYLIDENECARBENE-IODONIUM YLIDES FROM THE ADDITION OF NaN3 TO ALKYNYLPHENYLIODONIUM TOSYLATES

DOI: 10.1016/S0040-4039(00)82069-9

Source and publish data:

Tetrahedron Letters p. 1887 - 1890 (1988)

Update date:2022-08-17

Topics:

Authors:

Kitamura, Tsugio

Stang, Peter J.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/S0040-4039(00)82069-9

Addition of NaN3 to RC<*>CIPh(1+)*OTs(1-) results in novel alkylidenecarbene-iodonium ylides, 5, R(N3)C=C=IPh, that by either protonation, ylide transfer or insertion of the derived carbene R(N3)C=C: give unique functionalized vinyl azides.

Full text of DOI:10.1016/S0040-4039(00)82069-9

Products guided by the article

Product name:Iodobenzene

Cas No:591-50-4

R&D Labs maybe for 591-50-4

Tocopharm Co., Ltd.

Contact:+86-021-6989-5597

Address:No.80 Yichuan Rd., Putuo District,Shanghai,P.R.China
Zibo Xiaoguang Chemical Material Co., Ltd

Contact:15954099116

Address:Boshan Development Zone
Hangzhou Haiqiang Chemical Co.,Ltd.

Contact:+86-571-86960370

Address:Add: 5/F, Around Town North Road,No. 10, Hangzhou, Zhejiang,China
KINHENG CHEMICAL(SHANGHAI)CO., LTD.

Contact:+8621-60490170

Address:Room401, No.28,Lane 189, Yangshupu Rd. Shanghai, China.
Chongqing Yawei Fine Chemical Co.,Ltd

Contact:0086-23-62849407

Address:Ziyou village, Nanquan town, Banan district, Chongqing China

Relevant to this article

Silver-modulated SiO₂-supported copper catalysts for selective hydrogenation of dimethyl oxalate to ethylene glycol

Doi:10.1016/j.jcat.2013.07.006
(2013)
Doi:10.1557/JMR.2000.0207
(1929)
Cyclohexadienyl uranium complexes

Doi:10.1016/0022-328X(90)80235-R
(1990)
Peculiarities of electronic, phonon and magnon subsystems of lanthanum and samarium tetraborides

Doi:10.1016/j.jallcom.2015.06.101
(2015)
Highly value-added utilization of H₂S in Na₂SO₃solution over Ca-CdS nanocrystal photocatalysts

Doi:10.1039/d0cc05894g
(2020)
Process development for a key synthetic intermediate of LY2140023, a clinical candidate for the treatment of schizophrenia

Doi:10.1021/op100325h
(2011)

Article Doi